Novel Chikungunya Vaccine Candidate with an IRES-Based Attenuation and Host Range Alteration Mechanism

A Mouse Model of Chikungunya Virus–Induced Musculoskeletal Inflammatory Disease

(2011) Thomas E. Morrison et al.   AMERICAN JOURNAL OF PATHOLOGY

Design of Chimeric Alphaviruses with a Programmed, Attenuated, Cell Type-Restricted Phenotype

(2011) D. Y. Kim et al.   JOURNAL OF VIROLOGY

Stability of RNA virus attenuation approaches

(2011) Joan L. Kenney et al.   VACCINE

Genome-Scale Phylogenetic Analyses of Chikungunya Virus Reveal Independent Emergences of Recent Epidemics and Various Evolutionary Rates

(2010) S. M. Volk et al.   JOURNAL OF VIROLOGY

Chikungunya Virus Arthritis in Adult Wild-Type Mice

(2010) J. Gardner et al.   JOURNAL OF VIROLOGY

A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection

(2010) Wataru Akahata et al.   NATURE MEDICINE

Re-emergence of Chikungunya virus in South-east Asia: virological evidence from Sri Lanka and Singapore

(2009) H. C. Hapuarachchi et al.   JOURNAL OF GENERAL VIROLOGY

Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus

(2009) Mugdha Tiwari et al.   VACCINE

Neurologic Manifestations of Pediatric Chikungunya Infection

(2008) Stéphanie Robin et al.   JOURNAL OF CHILD NEUROLOGY

A Mouse Model for Chikungunya: Young Age and Inefficient Type-I Interferon Signaling Are Risk Factors for Severe Disease

(2008) Thérèse Couderc et al.   PLoS Pathogens

Chimeric alphavirus vaccine candidates for chikungunya

(2008) Eryu Wang et al.   VACCINE

Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus

(2008) Karuppiah Muthumani et al.   VACCINE

IRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cells

(2008) Eugenia Volkova et al.   VIROLOGY